Skip to main content
Top
Published in: Pituitary 3/2017

01-06-2017

Inhibition of neuronal nitric oxide synthase activity does not alter vasopressin secretion in septic rats

Authors: Camila Henriques Coelho, Thalita Freitas Martins, Gabriela Ravanelli Oliveira-Pelegrin, Maria José Alves da Rocha

Published in: Pituitary | Issue 3/2017

Login to get access

Abstract

Background/Purpose

During the early phase of sepsis, hypotension is accompanied by increase of plasma vasopressin hormone (AVP) levels, which decline during the late phase. This hypotension is due in part to increase of nitric oxide (NO) synthesis by nitric oxide synthase (NOS) enzyme. Neuronal isoform of this enzyme (nNOS) is present in vasopressinergics neurons of hypothalamus, but its role in vasopressin secretion during sepsis is unknown.

Methods

We evaluated the role of nNOS in NO production and vasopressin secretion during sepsis. Wistar rats received 7-nitroindazole (50 mg/kg, i.p.), an inhibitor of nNOS activity, or vehicle and were submitted to septic stimulus by cecal ligation and puncture (CLP). At the time points 0, 4, 6, 18 and 24 h after sepsis induction the animals were decapitated and neurohypophysis and hypothalamus were removed for analysis of vasopressin content and NOS activity, respectively. Hematocrit, serum sodium, osmolality, proteins and plasmatic AVP were quantified.

Results

Mortality was not affected by 7-nitroindazole (7-NI). Sodium and plasma proteins levels decreased after CLP and the treatment anticipated the protein loss, and delayed serum sodium decrease. Septic animals treated with 7-NI showed decrease of osmolality 4 h after CLP. Nitric oxide synthase activity in hypothalamus increased at 4 and 24 h after CLP and was reduced with 7-NI. Neurohypophysis content of AVP diminished after CLP and 7-NI did not alter this parameter. Plasma AVP levels increased at 6 h and decreased 18 and 24 h after CLP. Treatment with 7-NI did not alter plasma vasopressin levels.

Conclusion

We concluded that nNOS does not have a substantial role in vasopressin secretion during experimental sepsis.
Literature
1.
6.
go back to reference Ozer, E.K., Iskit, A.B.: Effects of endothelin and nitric oxide on cardiac muscle functions in experimental septic shock model. Human exp toxicol (2015). doi:10.1177/0960327115583363 Ozer, E.K., Iskit, A.B.: Effects of endothelin and nitric oxide on cardiac muscle functions in experimental septic shock model. Human exp toxicol (2015). doi:10.​1177/​0960327115583363​
7.
go back to reference Wahab F, Tazinafo LF, Carnio EC, Aguila FA, Batalhao ME, Rocha MJ (2015) Interleukin-1 receptor antagonist decreases cerebrospinal fluid nitric oxide levels and increases vasopressin secretion in the late phase of sepsis in rats. Endocrine 49(1):215–221. doi:10.1007/s12020-014-0452-2 CrossRefPubMed Wahab F, Tazinafo LF, Carnio EC, Aguila FA, Batalhao ME, Rocha MJ (2015) Interleukin-1 receptor antagonist decreases cerebrospinal fluid nitric oxide levels and increases vasopressin secretion in the late phase of sepsis in rats. Endocrine 49(1):215–221. doi:10.​1007/​s12020-014-0452-2 CrossRefPubMed
9.
go back to reference Ceccatelli S (1997) Expression and plasticity of NO synthase in the neuroendocrine system. Brain Res Bull 44(4):533–538CrossRefPubMed Ceccatelli S (1997) Expression and plasticity of NO synthase in the neuroendocrine system. Brain Res Bull 44(4):533–538CrossRefPubMed
11.
go back to reference Geller DA, Billiar TR (1998) Molecular biology of nitric oxide synthases. Cancer Metastasis Rev 17(1):7–23CrossRefPubMed Geller DA, Billiar TR (1998) Molecular biology of nitric oxide synthases. Cancer Metastasis Rev 17(1):7–23CrossRefPubMed
15.
go back to reference Huttunen R, Hurme M, Laine J, Eklund C, Vuento R, Aittoniemi J, Huhtala H, Syrjanen J (2009) Endothelial nitric oxide synthase G894T (GLU298ASP) polymorphism is associated with hypotension in patients with E. coli bacteremia but not in bacteremia caused by a gram-positive organism. Shock 31(5):448–453. doi:10.1097/SHK.0b013e318188e58e CrossRefPubMed Huttunen R, Hurme M, Laine J, Eklund C, Vuento R, Aittoniemi J, Huhtala H, Syrjanen J (2009) Endothelial nitric oxide synthase G894T (GLU298ASP) polymorphism is associated with hypotension in patients with E. coli bacteremia but not in bacteremia caused by a gram-positive organism. Shock 31(5):448–453. doi:10.​1097/​SHK.​0b013e318188e58e​ CrossRefPubMed
17.
go back to reference Nemzek JA, Xiao HY, Minard AE, Bolgos GL, Remick DG (2004) Humane endpoints in shock research. Shock 21(1):17–25CrossRefPubMed Nemzek JA, Xiao HY, Minard AE, Bolgos GL, Remick DG (2004) Humane endpoints in shock research. Shock 21(1):17–25CrossRefPubMed
18.
go back to reference Palkovits M, Brownstein MJ (1988) Maps and guide to microdissection of the rat brain. Elsevier, New York Palkovits M, Brownstein MJ (1988) Maps and guide to microdissection of the rat brain. Elsevier, New York
19.
go back to reference Marshall, J.C., Deitch, E., Moldawer, L.L., Opal, S., Redl, H., (2005) van der Poll, T.Preclinical models of shock and sepsis: what can they tell us? Shock 24 Suppl 1, 1–6 Marshall, J.C., Deitch, E., Moldawer, L.L., Opal, S., Redl, H., (2005) van der Poll, T.Preclinical models of shock and sepsis: what can they tell us? Shock 24 Suppl 1, 1–6
20.
go back to reference Remick, D.G., Ward, P.A (2005) Evaluation of endotoxin models for the study of sepsis. Shock 24 Suppl 1, 7–11 Remick, D.G., Ward, P.A (2005) Evaluation of endotoxin models for the study of sepsis. Shock 24 Suppl 1, 7–11
22.
go back to reference Hubbard, W.J., Choudhry, M., Schwacha, M.G., Kerby, J.D., Rue, L.W. Bland, K.I, Chaudry, I.H (2005) Cecal ligation and puncture. Shock 24 Suppl 1, 52–57 Hubbard, W.J., Choudhry, M., Schwacha, M.G., Kerby, J.D., Rue, L.W. Bland, K.I, Chaudry, I.H (2005) Cecal ligation and puncture. Shock 24 Suppl 1, 52–57
23.
go back to reference Torres-Duenas D, Benjamim CF, Ferreira SH, Cunha FQ (2006) Failure of neutrophil migration to infectious focus and cardiovascular changes on sepsis in rats: effects of the inhibition of nitric oxide production, removal of infectious focus, and antimicrobial treatment. Shock 25(3):267–276. doi:10.1097/01.shk.0000208804.34292.38 CrossRefPubMed Torres-Duenas D, Benjamim CF, Ferreira SH, Cunha FQ (2006) Failure of neutrophil migration to infectious focus and cardiovascular changes on sepsis in rats: effects of the inhibition of nitric oxide production, removal of infectious focus, and antimicrobial treatment. Shock 25(3):267–276. doi:10.​1097/​01.​shk.​0000208804.​34292.​38 CrossRefPubMed
24.
go back to reference Nardi GM, Scheschowitsch K, Ammar D, de Oliveira SK, Arruda TB, Assreuy J (2014) Neuronal nitric oxide synthase and its interaction with soluble guanylate cyclase is a key factor for the vascular dysfunction of experimental sepsis. Crit Care Med 42(6):e391–e400. doi:10.1097/CCM.0000000000000301 CrossRefPubMed Nardi GM, Scheschowitsch K, Ammar D, de Oliveira SK, Arruda TB, Assreuy J (2014) Neuronal nitric oxide synthase and its interaction with soluble guanylate cyclase is a key factor for the vascular dysfunction of experimental sepsis. Crit Care Med 42(6):e391–e400. doi:10.​1097/​CCM.​0000000000000301​ CrossRefPubMed
25.
go back to reference Enkhbaatar P, Murakami K, Shimoda K, Mizutani A, McGuire R, Schmalstieg F, Cox R, Hawkins H, Jodoin J, Lee S, Traber L, Herndon D, Traber D (2003) Inhibition of neuronal nitric oxide synthase by 7-nitroindazole attenuates acute lung injury in an ovine model. Am J Physiol Regul Integr Comp Physiol 285(2):R366–R372. doi:10.1152/ajpregu.00148.2003 CrossRefPubMed Enkhbaatar P, Murakami K, Shimoda K, Mizutani A, McGuire R, Schmalstieg F, Cox R, Hawkins H, Jodoin J, Lee S, Traber L, Herndon D, Traber D (2003) Inhibition of neuronal nitric oxide synthase by 7-nitroindazole attenuates acute lung injury in an ovine model. Am J Physiol Regul Integr Comp Physiol 285(2):R366–R372. doi:10.​1152/​ajpregu.​00148.​2003 CrossRefPubMed
27.
go back to reference Southan GJ, Szabo C (1996) Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem Pharmacol 51(4):383–394CrossRefPubMed Southan GJ, Szabo C (1996) Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem Pharmacol 51(4):383–394CrossRefPubMed
28.
go back to reference Zhang HQ, Fast W, Marletta MA, Martasek P, Silverman RB (1997) Potent and selective inhibition of neuronal nitric oxide synthase by N omega-propyl-L-arginine. J Med Chem 40(24):3869–3870. doi:10.1021/jm970550g CrossRefPubMed Zhang HQ, Fast W, Marletta MA, Martasek P, Silverman RB (1997) Potent and selective inhibition of neuronal nitric oxide synthase by N omega-propyl-L-arginine. J Med Chem 40(24):3869–3870. doi:10.​1021/​jm970550g CrossRefPubMed
29.
go back to reference Gocmez, S.S., Yazir, Y., Sahin, D., Karadenizli, S., Utkan, T (2015) The effect of a selective neuronal nitric oxide synthase inhibitor 3-bromo 7-nitroindazole on spatial learning and memory in rats. Pharmacol Biochem Behav 131, 19–25 doi:10.1016/j.pbb.2015.01.013 Gocmez, S.S., Yazir, Y., Sahin, D., Karadenizli, S., Utkan, T (2015) The effect of a selective neuronal nitric oxide synthase inhibitor 3-bromo 7-nitroindazole on spatial learning and memory in rats. Pharmacol Biochem Behav 131, 19–25 doi:10.​1016/​j.​pbb.​2015.​01.​013
30.
go back to reference Zhu, W., Su, J., Liu, J., Jiang, C (2015) The involvement of neuronal nitric oxide synthase in the anti-epileptic action of curcumin on pentylenetetrazol-kindled rats. Biomed Mater Eng 26 Suppl 1, S841–S850 doi:10.3233/BME-151376 Zhu, W., Su, J., Liu, J., Jiang, C (2015) The involvement of neuronal nitric oxide synthase in the anti-epileptic action of curcumin on pentylenetetrazol-kindled rats. Biomed Mater Eng 26 Suppl 1, S841–S850 doi:10.​3233/​BME-151376
31.
go back to reference Bush MA, Pollack GM (2000) Pharmacokinetics and protein binding of the selective neuronal nitric oxide synthase inhibitor 7-nitroindazole. Biopharmaceutics drug disposition 21(6):221–228CrossRefPubMed Bush MA, Pollack GM (2000) Pharmacokinetics and protein binding of the selective neuronal nitric oxide synthase inhibitor 7-nitroindazole. Biopharmaceutics drug disposition 21(6):221–228CrossRefPubMed
32.
go back to reference Kalisch BE, Connop BP, Jhamandas K, Beninger RJ, Boegman RJ (1996) Differential action of 7-nitro indazole on rat brain nitric oxide synthase. Neurosci Lett 219(2):75–78CrossRefPubMed Kalisch BE, Connop BP, Jhamandas K, Beninger RJ, Boegman RJ (1996) Differential action of 7-nitro indazole on rat brain nitric oxide synthase. Neurosci Lett 219(2):75–78CrossRefPubMed
35.
go back to reference Andrew P, Deng Y, Kaufman S (2000) Fluid extravasation from spleen reduces blood volume in endotoxemia. Am J Physiol Regul Integr Comp Physiol 278(1):R60–R65PubMed Andrew P, Deng Y, Kaufman S (2000) Fluid extravasation from spleen reduces blood volume in endotoxemia. Am J Physiol Regul Integr Comp Physiol 278(1):R60–R65PubMed
37.
go back to reference Xu, L., Carter, E.P., Ohara, M., Martin, P.Y., Rogachev, B., Morris, K., Cadnapaphornchai, M., Knotek, M., Schrier, R.W (2000) Neuronal nitric oxide synthase and systemic vasodilation in rats with cirrhosis. Am J physiol-Renal physiol 279(6), F1110–F1115 Xu, L., Carter, E.P., Ohara, M., Martin, P.Y., Rogachev, B., Morris, K., Cadnapaphornchai, M., Knotek, M., Schrier, R.W (2000) Neuronal nitric oxide synthase and systemic vasodilation in rats with cirrhosis. Am J physiol-Renal physiol 279(6), F1110–F1115
39.
go back to reference Byl B, Roucloux I, Crusiaux A, Dupont E, Deviere J (1993) Tumor necrosis factor alpha and interleukin 6 plasma levels in infected cirrhotic patients. Gastroenterology 104(5):1492–1497CrossRefPubMed Byl B, Roucloux I, Crusiaux A, Dupont E, Deviere J (1993) Tumor necrosis factor alpha and interleukin 6 plasma levels in infected cirrhotic patients. Gastroenterology 104(5):1492–1497CrossRefPubMed
Metadata
Title
Inhibition of neuronal nitric oxide synthase activity does not alter vasopressin secretion in septic rats
Authors
Camila Henriques Coelho
Thalita Freitas Martins
Gabriela Ravanelli Oliveira-Pelegrin
Maria José Alves da Rocha
Publication date
01-06-2017
Publisher
Springer US
Published in
Pituitary / Issue 3/2017
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-017-0786-x

Other articles of this Issue 3/2017

Pituitary 3/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.